全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Marcus J. Drake , Sally Bowditch , Emilio Arbe ...
来源:[J].BMC Urology(IF 1.694), 2017, Vol.17 (1)Springer
摘要:To assess treatment persistence and adherence in men ≥45 years of age with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), using prescription records from the Netherlands IMS Lifelink™ LRx database.
作者:Dora Pinheiro , João Machado , Carlos Viegas ...
来源:[J].BMC Veterinary Research(IF 1.861), 2017, Vol.13 (1)Springer
摘要:Benign prostatic hyperplasia (BPH) is the most common canine prostatic disorder. Although most or even all intact male dogs may develop BPH by 5–8 years of age, many show no clinical signs. Taking into account the non-specific character of clinical and ultrasonographic find...
作者:Faruk Kucukdurmaz , Erkan Efe , Ahmet Çelik ...
来源:[J].BMC Urology(IF 1.694), 2017, Vol.17 (1)Springer
摘要:Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are diseases of elderly men and are related to increased oxidative stress (OS). Although prolidase has a role in collagen metabolism, it is also used to evaluate OS in many diseases. However, there is a lack of data abo...
作者:Mahendra Kashyap , Subrata Pore , Zhou Wang ...
来源:[J].Journal of Inflammation(IF 2.554), 2015, Vol.12 (1)Springer
摘要:Abstract(#br) Background(#br)There is mounting evidence to support the role of inflammation in benign prostate hyperplasia (BPH), and a recent study reported expression of inflammasome derived cytokine IL-18 in prostate biopsy of BPH patients. Here we examined the expression of...
作者:Kuan-Chou Chen , Shian-Ying Sung , Yi-Ting Lin ...
来源:[J].BMC Urology(IF 1.694), 2015, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)Both benign prostatic hyperplasia (BPH) and Type-1 diabetes mellitus (T1DM) share similar epidemiologic features and are all associated with the insulin-like growth factor (IGF)-mediated hormonal imbalance. The purpose of this study is to understan...
作者:Su Kang Kim , Hosik Seok , Hae Jeong Park ...
来源:[J].BMC Complementary and Alternative Medicine(IF 2.082), 2015, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)Benign prostatic hyperplasia (BPH) is one of the common male diseases, which is provoked by dihydrotestosterone (DHT) and androgen signals. Several studies showed that curcumin has various effects of prevention and treatment to diseases. We investi...
作者:Yang Wang , Weihua Jiang , Hongmei Liu ...
来源:[J].Rice(IF 2.381), 2017, Vol.10 (1)Springer
摘要:The brown planthopper (BPH) has become the most destructive and a serious threat to the rice production in Asia. Breeding the resistant varieties with improved host resistance is the most effective and ecosystem-friendly strategy of BPH biological management. As host resistance w...
作者:Hongbo Wang , Shengtuo Ye , Tongmin Mou
来源:[J].Rice(IF 2.381), 2016, Vol.9 (1), pp.1-9Springer
摘要:... However, the brown planthopper (BPH), Nilaparvata lugens Stål, causes severe yield loss of rice ( Oryza sativa L.) and can threaten food security. Therefore, breeding hybrid rice resistant to BPH is the most effective and economical strategy to maintain high and stable ...
作者:Giuseppe Morgia , Antonio Micali , Mariagrazia Rinaldi ...
来源:[J].International Journal of Molecular Sciences(IF 2.464), 2017, Vol.18 (3)DOAJ
摘要:Benign prostatic hyperplasia (BPH) treatment includes the apoptosis machinery modulation through the direct inhibition of caspase cascade. We previously demonstrated that Serenoa repens (Ser) with lycopene (Ly) and selenium (Se) reawakened apoptosis by reducing survivin and neuro...
作者:Airton Mota Moreira , André Moreira de Assis , Francisco Cesar Carnevale ...
来源:[J].CardioVascular and Interventional Radiology(IF 2.138), 2017, Vol.40 (10), pp.1490-1500Springer
摘要:Minimally invasive procedures have gained great importance among the treatments for benign prostate hyperplasia (BPH) due to their low morbidity. Prostate artery embolization has emerged as a safe and effective alternative for patients with large volume BPH, not suited for surger...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×